Pediatric nonalcoholic fatty liver disease

Pediatric Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease Treatment

Nonalcoholic fatty liver disease (NAFLD) is increasing in pediatric age group parallel to the growing prevalence of obesity and overweight all around the world. So changing in life style and   interventions on obesogenic environment is cornerstone of NAFLD therapy in obese children. Some experts recommend that children and adolescents be encouraged to follow a low-fat, low-glycemic-index diet t...

Pediatric nonalcoholic fatty liver disease in 2009.

W ithin the so-called ‘‘globesity’’ epidemic, the International Obesity Task Force estimated that there at least 155 million persons are overweight/obese, including 30 to 45 million obese children worldwide. In parallel with epidemic obesity, nonalcoholic fatty liver disease (NAFLD) has also been increasingly recognized worldwide in the last decade. At present, NAFLD is identified as an importa...

Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is known to be associated with an increased risk of colorectal cancer (CRC). However, the relationship between NAFLD and the prognosis of CRC remains unclear. The primary objective of this study was to evaluate the overall survival (OS) and disease-free survival (DFS) rates in patients with CRC and the secondary objective was to compare clinicopathologic...

Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (or NAFLD) is a recently recognized chron­ ic liver disease, strongly linked to obesity. As the number of obese Americans has doubled in the past three decades, not sur­ prisingly, NAFLD is becoming increasingly common. The hallmark of persons with NAFLD is having too much fat in the liver. This fat is deposited within the cells of the liver (the medical term is...